Works matching IS 13570560 AND DT 2024 AND VI 41 AND IP 11
Results: 50
Recent advancements in cGAS-STING activation, tumor immune evasion, and therapeutic implications.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02539-7
- By:
- Publication type:
- Article
Introducing the ELPIS scale: a novel tool for measuring emotional empathy toward cancer patients.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02537-9
- By:
- Publication type:
- Article
Advancements in long non-coding RNA-based therapies for cancer: targeting, delivery, and clinical implications.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02534-y
- By:
- Publication type:
- Article
Modulation of the tumor microenvironment in non-muscle-invasive bladder cancer by OncoTherad® (MRB-CFI-1) nanoimmunotherapy: effects on tumor-associated macrophages, tumor-infiltrating lymphocytes, and monoamine oxidases.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Personalized oncology in pheochromocytomas and paragangliomas: integrating genetic analysis with machine learning.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02532-0
- By:
- Publication type:
- Article
Pancancer analysis of NDUFA4L2 with focused role in tumor progression and metastasis of colon adenocarcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02531-1
- By:
- Publication type:
- Article
Transforming cancer detection and treatment with nanoflowers.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02530-2
- By:
- Publication type:
- Article
Comparative evaluation of anticancer potential of Spilanthes paniculata leaf and flower essential oil using annexin V and orosphere formation in oral cancer cell line.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02523-1
- By:
- Publication type:
- Article
siRNA-based strategies to combat drug resistance in gastric cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02528-w
- By:
- Publication type:
- Article
Camptothecin and its derivatives: Advancements, mechanisms and clinical potential in cancer therapy.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02527-x
- By:
- Publication type:
- Article
DDX3X dynamics, glioblastoma's genetic landscape, therapeutic advances, and autophagic interplay.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02525-z
- By:
- Publication type:
- Article
Centromeres in cancer: Unraveling the link between chromosomal instability and tumorigenesis.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02524-0
- By:
- Publication type:
- Article
Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02529-9
- By:
- Publication type:
- Article
Treating endometrial hyperplasia (EH) post-tamoxifen treatment in breast cancer survivors: what are our options?
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02522-2
- By:
- Publication type:
- Article
Letter to Editor "Possible protective effect of rosuvastatin in chemotherapy‑induced cardiotoxicity in HER2-positive breast cancer patients: a randomized controlled trial".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Hormones as a double-edged sword: the role of hormones in cancer progression and the potential of targeted hormone therapies.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02517-z
- By:
- Publication type:
- Article
YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02516-0
- By:
- Publication type:
- Article
PI3K/AKT/mTOR inhibitors for the management of triple-negative breast cancer.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Regulation of autophagy by non-coding RNAs in human glioblastoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02513-3
- By:
- Publication type:
- Article
Analysis of the mechanisms underlying the anticancer and biological activity of retinoic acid and chitosan nanoparticles containing retinoic acid.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02512-4
- By:
- Publication type:
- Article
DNA fragmentation factor 40-based therapeutic approaches for cancer: a review article.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02511-5
- By:
- Publication type:
- Article
Evidence-based recommendations regarding risk reduction practices for people at risk of or with breast cancer-related lymphedema: consensus from an expert panel.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Progress in lymphedema.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17β-estradiol on cancer progression.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02508-0
- By:
- Publication type:
- Article
Glycolytic pathway analysis and gene expression profiles of combination of aloe vera and paclitaxel on non-small cell lung cancer and breast cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02506-2
- By:
- Publication type:
- Article
Personalized treatment approach for HER2-positive metastatic breast cancer.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02504-4
- By:
- Publication type:
- Article
Letter to the editor: Comment on "possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial".
- Published in:
- 2024
- By:
- Publication type:
- Letter
The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02501-7
- By:
- Publication type:
- Article
Personalized oncology, ethics and adherence to NCCN guidelines.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02500-8
- By:
- Publication type:
- Article
Comment on "Gd-GQDs as nanotheranostic platform for the treatment of HPV-positive oropharyngeal cancer".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Comment on "Anticancer effects of Artemisia campestris extract on acute myeloid leukemia cells: an ex vivo study".
- Published in:
- 2024
- By:
- Publication type:
- Letter
The role of kinesin superfamily proteins in hepatocellular carcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02497-0
- By:
- Publication type:
- Article
Gamma-butyrobetaine hydroxylase (BBOX1) exerts suppressive effects on HepG2 hepatoblastoma cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02496-1
- By:
- Publication type:
- Article
Letter to the editor: Comment on "Citalopram, an antipsychotic agent, induces G1/G0 phase cell cycle arrest and promotes apoptosis in human laryngeal carcinoma HEP-2 cells".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Clinical research on triple-negative breast cancer that targets the PIK3CA pathway.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02491-6
- By:
- Publication type:
- Article
Polydatin inhibits histone deacetylase 1 and shows an anti-angiogenic action in head and neck squamous cell carcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02490-7
- By:
- Publication type:
- Article
Vaccine-based therapeutic interventions in lung cancer management: A recent perspective.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02489-0
- By:
- Publication type:
- Article
The impact of Trifolium pratense extract on apoptosis and autophagy in NALM-6 cells: implications for B-ALL intervention.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02485-4
- By:
- Publication type:
- Article
The influence of non-cancer-related risk factors on the development of cancer-related lymphedema: a rapid review.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02474-7
- By:
- Publication type:
- Article
Consensus statement on non-cancer-related risk factors for development of secondary lymphedema.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Expert-consensus on lymphedema surgeries: candidacy, prehabilitation, and postoperative care.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
The effect of compression therapies and therapeutic modalities on lymphedema secondary to cancer: a rapid review and evidence map.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02447-w
- By:
- Publication type:
- Article
M1 macrophages deliver CASC19 via exosomes to inhibit the proliferation and migration of colon cancer cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02444-z
- By:
- Publication type:
- Article
Essential components of the maintenance phase of complex decongestive therapy.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Effectiveness of complete decongestive therapy for upper extremity breast cancer-related lymphedema: a review of systematic reviews.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02421-6
- By:
- Publication type:
- Article
Post-operative care for patients following surgical treatment of lymphedema.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Targeting telomerase with MST-312 leads to downregulation of CCND1, MDM2, MYC, and HSP90AA1 and induce apoptosis in Jurkat cell line.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02412-7
- By:
- Publication type:
- Article
Current evidence on patient precautions for reducing breast cancer-related lymphedema manifestation and progression risks.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02408-3
- By:
- Publication type:
- Article
PARP1 acetylation at K119 is essential in regulating the progression and proliferation of cervical cancer cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 11, p. 1, doi. 10.1007/s12032-024-02315-7
- By:
- Publication type:
- Article